@article{7578,
  keywords = {Adolescent, Adult, Age Factors, BCG Vaccine, Brazil, Case-Control Studies, Humans, Incidence, leprosy, Mycobacterium leprae, Sensitivity and Specificity, Time Factors, Treatment Outcome, Vaccination},
  author = {Rodrigues L and Kerr-Pontes LRS and Frietas MVC and Barreto ML},
  title = {Long lasting BCG protection against leprosy.},
  abstract = {<p><b>BACKGROUND: </b>BCG vaccine protects against leprosy.</p><p><b>OBJECTIVES: </b>Estimate BCG protection against leprosy by age by age.</p><p><b>METHODS: </b>A case control study with 226 cases of leprosy and 857 controls. BCG vaccination was ascertained via examination of BCG scars. Protection is presented for three age groups.</p><p><b>RESULTS: </b>BCG protection against leprosy was 86% (95% CI: 77-92%) in the age group 18-29; 54% (95% CI: -37% to 85%) in the age group 30-39 and 32% (95% CI: -3% to 56%) in those aged 40 or more.</p><p><b>CONCLUSIONS: </b>BCG efficacy against leprosy may well last for three decades and possibly even longer. BCG vaccination must have contributed to worldwide reduction in leprosy incidence.</p>},
  year = {2007},
  journal = {Vaccine},
  volume = {25},
  pages = {6842-4},
  month = {2007 Sep 28},
  issn = {0264-410X},
  doi = {10.1016/j.vaccine.2007.07.032},
  language = {eng},
}